485 Acetate Is a Bioenergetic Substrate for Human Glioblastoma and Brain Metastases.
http://www.cell.com/cell/abstract/S0092-8674(14)01502-5
484 In vivo selective cancer-tracking gadolinium eradicator as new-generation photodynamic therapy agent.
http://www.pnas.org/content/111/51/E5492.abstract
483 A stem cell model of a lethal brain tumor in children shows how a recurrent histone mutation leads to cancer.
http://www.sciencemag.org/content/346/6216/1529.abstract
482 Dissecting the clonal origins of childhood acute lymphoblastic leukemia by single-cell genomics.
http://www.pnas.org/content/111/50/17947.abstract
481 The Wilms’ tumour suppressor Wt1 is a major regulator of tumour angiogenesis and progression.
http://www.nature.com/ncomms/2014/141216/ncomms6852/full/ncomms6852.html
480 Detection of cancer biomarkers in serum using a hybrid mechanical and optoplasmonic nanosensor.
http://www.nature.com/nnano/journal/v9/n12/abs/nnano.2014.250.html
479 Leukemia-associated mutations drive cell growth by creating a powerful transcriptional enhancer upstream of an oncogene.
http://www.sciencemag.org/content/346/6215/1373.abstract
478 Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma.
http://www.nature.com/nm/journal/v20/n12/abs/nm.3716.html
477 Disruption of FAT10–MAD2 binding inhibits tumor progression.
http://www.pnas.org/content/111/49/E5282.abstract
476 RHOA inactivation enhances Wnt signalling and promotes colorectal cancer.
http://www.nature.com/ncomms/2014/141121/ncomms6458/full/ncomms6458.html
475 Discovery and characterization of small molecules that target the GTPase Ral.
http://www.nature.com/nature/journal/v515/n7527/full/nature13713.html
474 Genomic landscape of metastatic colorectal cancer.
http://www.nature.com/ncomms/2014/141114/ncomms6457/full/ncomms6457.html
473 A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer.
http://www.nature.com/nm/journal/v20/n11/abs/nm.3646.html
472 Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer.
http://www.nature.com/nature/journal/v515/n7525/full/nature13638.html
471 Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis.
http://www.nature.com/nature/journal/v515/n7525/full/nature13862.html
470 Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity.
http://stm.sciencemag.org/content/6/261/261ra151
469 Antitumor effects and molecular mechanisms of figitumumab, a humanized monoclonal antibody to IGF-1 receptor, in esophageal carcinoma.
http://www.nature.com/srep/2014/141031/srep06855/full/srep06855.html
468 Cyclin C is a haploinsufficient tumour suppressor.
http://www.nature.com/ncb/journal/v16/n11/abs/ncb3046.html
467 Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe.
http://stm.sciencemag.org/content/6/260/260ra149
466 Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer.
http://www.pnas.org/content/111/42/15172.abstract
|
